LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark
Nordic Journal of Psychiatry July 5, 2017 DOI: 10.1080/08039488.2017.1336251 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Retrospective cohort study Peer reviewed |
|---|---|
| Population | Mental health patients |
| Interventions | LSD psilocybin |
| Topics | Psilocybin LSD |
| Keywords | Danish Hallucinogen Retrospective cohort study Neurosis Mental health |
| Citations | 15 |
| Key findings | The use of LSD and psilocybin in mental health patients may be associated with serious short- and long-term side effects. |
Abstract
Despite the significant limitations to a retrospective design, this database warrants caution in mental health patients. The use of LSD and psilocybin in mental health patients may be associated with serious short- and long-term side effects. Until further trials with rigorous designs have cleared these drugs of their potential harms, their clinical utility in these groups of patients has not been fully clarified.
Comparable studies
Other observational and cohort studies on LSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution. Human participants | 2016 | Observational cohort | |
| Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans | 2017 | Observational study | |
| Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) | 2015 | Observational cohort | n = 190,000 |
| Psychedelics not linked to mental health problems or suicidal behavior: A population study Randomly selected United States adults | 2015 | Observational cohort | n = 135,095 |
| Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Healthy human participants | 2018 | Observational study with computational modeling |
Citations in the library
Cited by 13
- Lysergic Acid Diethylamide and Psilocybin for the Management of Patients with Persistent Pain: a Potential Role? Pain Management May 1, 2018
- Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis. Cureus November 1, 2022
- Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder Journal of Psychopharmacology December 14, 2022
- Lessons to be learned from early psychedelic therapy in Denmark Nordic Journal of Psychiatry July 20, 2017
- Psychedelics and the treatment of eating disorders: considerations for future research and practice. Journal of Eating Disorders October 22, 2024
and 8 more in the library
Cites 16
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
and 11 more in the library